Literature DB >> 32088728

Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma.

Bo Zhang1, Yan Chen1, Xiaolei Shi2, Mi Zhou1, Lei Bao1, Kimmo J Hatanpaa1, Toral Patel3,4, Ralph J DeBerardinis2, Yingfei Wang5,6, Weibo Luo7,8.   

Abstract

Hypoxia-inducible factors (HIFs) mediate metabolic reprogramming in response to hypoxia. However, the role of HIFs in branched-chain amino acid (BCAA) metabolism remains unknown. Here we show that hypoxia upregulates mRNA and protein levels of the BCAA transporter LAT1 and the BCAA metabolic enzyme BCAT1, but not their paralogs LAT2-4 and BCAT2, in human glioblastoma (GBM) cell lines as well as primary GBM cells. Hypoxia-induced LAT1 protein upregulation is mediated by both HIF-1 and HIF-2 in GBM cells. Although both HIF-1α and HIF-2α directly bind to the hypoxia response element at the first intron of the human BCAT1 gene, HIF-1α is exclusively responsible for hypoxia-induced BCAT1 expression in GBM cells. Knockout of HIF-1α and HIF-2α significantly reduces glutamate labeling from BCAAs in GBM cells under hypoxia, which provides functional evidence for HIF-mediated reprogramming of BCAA metabolism. Genetic or pharmacological inhibition of BCAT1 inhibits GBM cell growth under hypoxia. Together, these findings uncover a previously unrecognized HIF-dependent metabolic pathway that increases GBM cell growth under conditions of hypoxic stress.

Entities:  

Keywords:  Branched-chain amino acid; Gene regulation; Glioblastoma; Hypoxia; Hypoxia-inducible factor; Metabolism

Mesh:

Substances:

Year:  2020        PMID: 32088728      PMCID: PMC8112551          DOI: 10.1007/s00018-020-03483-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  43 in total

1.  Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport.

Authors:  Chendong Yang; Bookyung Ko; Christopher T Hensley; Lei Jiang; Ajla T Wasti; Jiyeon Kim; Jessica Sudderth; Maria Antonietta Calvaruso; Lloyd Lumata; Matthew Mitsche; Jared Rutter; Matthew E Merritt; Ralph J DeBerardinis
Journal:  Mol Cell       Date:  2014-10-21       Impact factor: 17.970

2.  Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells.

Authors:  Elitsa A Ananieva; Chirag H Patel; Charles H Drake; Jonathan D Powell; Susan M Hutson
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

3.  JPH203, an L-type amino acid transporter 1-selective compound, induces apoptosis of YD-38 human oral cancer cells.

Authors:  Dae-Woong Yun; Seul Ah Lee; Min-Gyeong Park; Jae-Sung Kim; Sun-Kyoung Yu; Mi-Ra Park; Su-Gwan Kim; Ji-Su Oh; Chun Sung Kim; Heung-Joong Kim; Jin-Soo Kim; Hong Sung Chun; Yoshikatsu Kanai; Hitoshi Endou; Michael F Wempe; Do Kyung Kim
Journal:  J Pharmacol Sci       Date:  2014-02-04       Impact factor: 3.337

4.  Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.

Authors:  Weibo Luo; Hongxia Hu; Ryan Chang; Jun Zhong; Matthew Knabel; Robert O'Meally; Robert N Cole; Akhilesh Pandey; Gregg L Semenza
Journal:  Cell       Date:  2011-05-27       Impact factor: 41.582

5.  L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.

Authors:  Hiroshi Nawashiro; Naoki Otani; Nariyoshi Shinomiya; Shinji Fukui; Hidetoshi Ooigawa; Katsuji Shima; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Int J Cancer       Date:  2006-08-01       Impact factor: 7.396

6.  HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.

Authors:  Ainara Elorza; Inés Soro-Arnáiz; Florinda Meléndez-Rodríguez; Victoria Rodríguez-Vaello; Glenn Marsboom; Guillermo de Cárcer; Bárbara Acosta-Iborra; Lucas Albacete-Albacete; Angel Ordóñez; Leticia Serrano-Oviedo; Jose Miguel Giménez-Bachs; Alicia Vara-Vega; Antonio Salinas; Ricardo Sánchez-Prieto; Rafael Martín del Río; Francisco Sánchez-Madrid; Marcos Malumbres; Manuel O Landázuri; Julián Aragonés
Journal:  Mol Cell       Date:  2012-10-25       Impact factor: 17.970

7.  Roles for cysteine residues in the regulatory CXXC motif of human mitochondrial branched chain aminotransferase enzyme.

Authors:  Myra E Conway; Leslie B Poole; Susan M Hutson
Journal:  Biochemistry       Date:  2004-06-15       Impact factor: 3.162

Review 8.  The small SLC43 family: facilitator system l amino acid transporters and the orphan EEG1.

Authors:  Susanna Bodoy; Dimitrios Fotiadis; Claudia Stoeger; Yoshikatsu Kanai; Manuel Palacín
Journal:  Mol Aspects Med       Date:  2012-12-23

9.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

10.  BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.

Authors:  Zhi-Qiang Wang; Adnen Faddaoui; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Chantal Guillemette; Stéphane Gobeil; Elizabeth Macdonald; Barbara Vanderhyden; Dimcho Bachvarov
Journal:  Oncotarget       Date:  2015-10-13
View more
  20 in total

1.  HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression.

Authors:  Lisha Xiang; Yongsheng Wang; Jie Lan; Feifei Na; Shuang Wu; Yuzhu Gong; Hanjian Du; Bin Shao; Ganfeng Xie
Journal:  Cell Mol Life Sci       Date:  2022-06-04       Impact factor: 9.261

Review 2.  Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators?

Authors:  Lenka Rossmeislová; Jan Gojda; Katarína Smolková
Journal:  Cancer Metastasis Rev       Date:  2021-12-28       Impact factor: 9.264

3.  KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response.

Authors:  Mingming Yang; Chenliang Wang; Mi Zhou; Lei Bao; Yanan Wang; Ashwani Kumar; Chao Xing; Weibo Luo; Yingfei Wang
Journal:  Nucleic Acids Res       Date:  2022-06-24       Impact factor: 19.160

4.  Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma.

Authors:  Bo Zhang; Hui Peng; Mi Zhou; Lei Bao; Chenliang Wang; Feng Cai; Hongxia Zhang; Jennifer E Wang; Yanling Niu; Yan Chen; Yijie Wang; Kimmo J Hatanpaa; John A Copland; Ralph J DeBerardinis; Yingfei Wang; Weibo Luo
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

Review 5.  Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation.

Authors:  Chelsea Schiliro; Bonnie L Firestein
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

Review 6.  Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.

Authors:  Joseph Chen; Hyunchul Lee; Philipp Schmitt; Caleb J Choy; Donald M Miller; Brian J Williams; Elaine L Bearer; Hermann B Frieboes
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-15       Impact factor: 3.148

7.  Metabolic adaptations to hypoxia in the neonatal mouse forebrain can occur independently of the transporters SLC7A5 and SLC3A2.

Authors:  Eamon Fitzgerald; Jennie Roberts; Daniel A Tennant; James P Boardman; Amanda J Drake
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.996

8.  Hypoxia enhances the production and antitumor effect of exosomes derived from natural killer cells.

Authors:  Yanan Jiang; Haiming Jiang; Kun Wang; Chunling Liu; Xuejing Man; Qiang Fu
Journal:  Ann Transl Med       Date:  2021-03

Review 9.  Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.

Authors:  Falko Lange; Julia Hörnschemeyer; Timo Kirschstein
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

Review 10.  Metabolic Constrains Rule Metastasis Progression.

Authors:  Niccolo' Roda; Valentina Gambino; Marco Giorgio
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.